GlassScriptPhysician profile
Lucia Enriquez
NPI 1639882772
$387.70
in general payments reported to CMS, 2019-2025
13 companies · $165 in 2025
The $165 reported for 2025 was more than what a typical Obstetrics & Gynecology (Nurse Practitioner) provider received nationally (typical 2025 total: $151).
See the full distribution for Obstetrics & Gynecology (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $77.97 · 2024: $145 · 2025: $165.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $388.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $387.70 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Organon LLC | $57.56 | 2024-2025 | Nexplanon, Jada System |
| Millicent US INC | $56.42 | 2025 | Femlyv, Intrarosa |
| Aspira Women'S Health INC | $53.92 | 2024 | Ova1 |
| Mayne Pharma Commercial LLC | $34.20 | 2024-2025 | |
| Biogen, INC. | $24.76 | 2024 | Zurzuvae |
| Shield Therapeutics INC | $24.23 | 2025 | |
| Astellas Pharma US INC | $24.04 | 2024 | Veozah |
| Axsome Therapeutics, INC. | $24.01 | 2023 | Auvelity |
| Hologic Sales and Service, LLC | $20.93 | 2025 | Fetal Fibronectin Enzyme Immunoassay |
| Agile Therapeutics, INC. | $19.88 | 2023 | Twirla |
| Daiichi Sankyo INC. | $19.57 | 2023 | Injectafer |
| Avion Pharmaceuticals | $14.51 | 2023 | Balcoltra |
| Exact Sciences Corporation | $13.67 | 2024 | Cologuard Collection Kit |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lucia Enriquez listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.